- Transaction values Avertix at an enterprise value of $195 million- Avertix developed the Guardian™ System, the first and only...
PALO ALTO, Calif. and MIAMI, Fla., May 03, 2023 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the...
Recognizing exceptional leadership in patient education and clinical skill in the Barrigel procedure SANTA BARBARA, Calif. and STOCKHOLM, Sweden, May...
US Digestive Health relocates gastroenterologist office from Brandywine to join affiliated endoscopy center in Downingtown, PA. US Digestive Health relocates...
Solera’s technology platform enables payers and employers to offer members seamless access to digital and community-based solutions to manage their...
Southlake, Texas, May 02, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”),...
Casana obtained FDA clearance for measuring Heart Rate (HR) and Oxygen Saturation (SpO2)Sensors embedded in the toilet seat enable effortless...
FIREFLY-1 clinical abstract selected for oral presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting Leadership team...
Nanox.ARC Image of the Nanox ARC Nanox.ARC Image of the Nanox ARCNanox.ARC presents high powered digital X-ray tubes for 3D...
Strategic role strengthens NeuroStar® Advanced Therapy commercialization teamMALVERN, Pa., May 01, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a...
VANCOUVER, British Columbia, May 01, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional...
MIAMI and BARRANQUILLA, Colombia, May 01, 2023 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a...
CORAL GABLES, Fla., May 01, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused...
Dr. Newman also to give two presentations on the Company’s Decoy platform at the event to be held in Boston...
DENVER, May 01, 2023 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare...
With funding, ODAIA to fuel expansion and support the rapid growth of its AI-powered solutions that help pharma companies put...
Development of lead asset nomacopan, a novel dual-mechanism inhibitor of complement C5 and leukotriene B4 (LTB4), is focused on two...
OTTAWA, May 01, 2023 (GLOBE NEWSWIRE) -- The Canadian Dermatology Association (CDA) launches its month-long Sun Awareness Month campaign, urging...
First quarter 2023 BRIUMVI net sales of $7.8 million Over 400 BRIUMVI prescriptions in the first partial quarter from 165+...
FORT WORTH, Texas, May 01, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (“the Company”), a clinical-stage biopharmaceutical company...